Breast cancer type 1 susceptibility protein (Brca1) was originally cloned as a human tumor suppressor, with mutations in the gene associated with an increased risk of developing breast and ovarian cancers [1,2]. The gene discussed is BRCA1; the disease is ovarian carcinoma.